Oxbryta
List of products in the National Drug Code with proprietary name oxbryta. This medication is used to treat sickle cell disease. People with sickle cell disease have a certain abnormal protein (hemoglobin S) in their red blood cells that makes the cells stiff and irregularly shaped (sickle- or crescent moon-shaped). Voxelotor works by decreasing hemoglobin S. This effect may decrease symptoms such as tiredness, shortness of breath, and attacks of pain (sickle cell crisis).
NDC | Proprietary Name | Non-Proprietary Name | Dosage Form | Route Name | Labeler Name | Product Type |
---|---|---|---|---|---|---|
72786-101 | Oxbryta | Voxelotor | Tablet, Film Coated | Oral | Global Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc. | Human Prescription Drug |
72786-102 | Oxbryta | Voxelotor | Tablet, Film Coated | Oral | Global Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc. | Human Prescription Drug |
72786-111 | Oxbryta | Voxelotor | Tablet, For Suspension | Oral | Global Blood Therapeutics, Inc, A Subsidiary Of Pfizer Inc. | Human Prescription Drug |